| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thoracic Surgery | 45 | 2024 | 725 | 6.510 |
Why?
|
| Heart Defects, Congenital | 155 | 2024 | 4673 | 6.210 |
Why?
|
| Cardiac Surgical Procedures | 124 | 2024 | 3620 | 5.990 |
Why?
|
| Heart Valve Prosthesis | 50 | 2023 | 1495 | 3.690 |
Why?
|
| Bioprosthesis | 31 | 2023 | 600 | 3.120 |
Why?
|
| Societies, Medical | 40 | 2024 | 3905 | 2.670 |
Why?
|
| Pulmonary Valve | 31 | 2023 | 414 | 2.530 |
Why?
|
| Tissue Engineering | 34 | 2023 | 1870 | 2.380 |
Why?
|
| Sheep | 78 | 2023 | 1441 | 2.360 |
Why?
|
| Transposition of Great Vessels | 41 | 2023 | 590 | 2.210 |
Why?
|
| Heart Arrest, Induced | 26 | 2003 | 357 | 2.150 |
Why?
|
| Pulmonary Artery | 58 | 2021 | 1921 | 2.080 |
Why?
|
| Databases, Factual | 47 | 2024 | 8035 | 2.040 |
Why?
|
| Fontan Procedure | 37 | 2018 | 791 | 1.740 |
Why?
|
| Heart Valves | 15 | 2021 | 285 | 1.710 |
Why?
|
| Myocardial Reperfusion Injury | 22 | 2002 | 479 | 1.640 |
Why?
|
| Cardiovascular Surgical Procedures | 7 | 2021 | 192 | 1.290 |
Why?
|
| Tetralogy of Fallot | 25 | 2023 | 631 | 1.210 |
Why?
|
| Hospital Mortality | 36 | 2024 | 5425 | 1.200 |
Why?
|
| Heart Septal Defects, Ventricular | 33 | 2023 | 491 | 1.190 |
Why?
|
| Hypothermia, Induced | 26 | 2008 | 758 | 1.180 |
Why?
|
| Postoperative Complications | 90 | 2021 | 15697 | 1.170 |
Why?
|
| Biomedical Engineering | 9 | 2009 | 289 | 1.080 |
Why?
|
| Heart Valve Prosthesis Implantation | 19 | 2019 | 1582 | 1.060 |
Why?
|
| Animals, Newborn | 32 | 2016 | 2672 | 1.030 |
Why?
|
| Abnormalities, Multiple | 25 | 2016 | 1415 | 1.010 |
Why?
|
| Blood Vessel Prosthesis | 19 | 2014 | 956 | 0.970 |
Why?
|
| Cardiopulmonary Bypass | 30 | 2009 | 1096 | 0.950 |
Why?
|
| Pulmonary Atresia | 11 | 2023 | 159 | 0.940 |
Why?
|
| Infant | 197 | 2024 | 36060 | 0.930 |
Why?
|
| Polymers | 17 | 2023 | 1621 | 0.920 |
Why?
|
| Endothelial Cells | 12 | 2023 | 3539 | 0.900 |
Why?
|
| Endothelium, Vascular | 28 | 2018 | 4433 | 0.900 |
Why?
|
| Heart Ventricles | 39 | 2023 | 3811 | 0.870 |
Why?
|
| Infant, Newborn | 145 | 2024 | 26181 | 0.860 |
Why?
|
| Truncus Arteriosus, Persistent | 9 | 2023 | 63 | 0.860 |
Why?
|
| Cardioplegic Solutions | 11 | 1995 | 122 | 0.850 |
Why?
|
| Heart Septal Defects, Atrial | 8 | 2020 | 461 | 0.840 |
Why?
|
| Prosthesis Failure | 8 | 2019 | 1206 | 0.800 |
Why?
|
| Coronary Circulation | 20 | 2007 | 1577 | 0.770 |
Why?
|
| Heart Valve Diseases | 13 | 2023 | 1047 | 0.750 |
Why?
|
| Culture Techniques | 6 | 2008 | 530 | 0.750 |
Why?
|
| Child, Preschool | 147 | 2024 | 42063 | 0.740 |
Why?
|
| Coronary Artery Bypass | 12 | 2015 | 2272 | 0.710 |
Why?
|
| Thoracic Surgical Procedures | 8 | 2019 | 348 | 0.710 |
Why?
|
| Registries | 23 | 2021 | 8469 | 0.710 |
Why?
|
| Myocardial Reperfusion | 8 | 1997 | 347 | 0.700 |
Why?
|
| Heart | 12 | 2020 | 4393 | 0.690 |
Why?
|
| Aortic Valve | 16 | 2019 | 1996 | 0.670 |
Why?
|
| Ventricular Outflow Obstruction | 10 | 2021 | 265 | 0.660 |
Why?
|
| Polyesters | 10 | 2023 | 372 | 0.650 |
Why?
|
| Palliative Care | 22 | 2021 | 3607 | 0.640 |
Why?
|
| Aorta, Thoracic | 11 | 2023 | 1097 | 0.630 |
Why?
|
| Weight Lifting | 2 | 2014 | 126 | 0.630 |
Why?
|
| Hypoplastic Left Heart Syndrome | 14 | 2018 | 594 | 0.620 |
Why?
|
| Cardiac Output | 7 | 2009 | 838 | 0.610 |
Why?
|
| Coronary Vessel Anomalies | 15 | 2019 | 317 | 0.610 |
Why?
|
| Aortic Valve Insufficiency | 9 | 2023 | 584 | 0.590 |
Why?
|
| Biocompatible Materials | 15 | 2023 | 1689 | 0.590 |
Why?
|
| Humans | 444 | 2024 | 760621 | 0.590 |
Why?
|
| Heart Transplantation | 13 | 2024 | 3224 | 0.590 |
Why?
|
| Vascular Surgical Procedures | 9 | 2018 | 1475 | 0.590 |
Why?
|
| Hemodynamics | 35 | 2017 | 4174 | 0.590 |
Why?
|
| Stem Cells | 10 | 2011 | 3523 | 0.580 |
Why?
|
| Arginine | 6 | 2003 | 934 | 0.570 |
Why?
|
| Aortic Valve Stenosis | 10 | 2018 | 2065 | 0.570 |
Why?
|
| Reoperation | 45 | 2024 | 4291 | 0.570 |
Why?
|
| Heart Bypass, Right | 8 | 2008 | 75 | 0.560 |
Why?
|
| Benchmarking | 7 | 2017 | 1044 | 0.550 |
Why?
|
| Heart Septal Defects | 7 | 2018 | 191 | 0.540 |
Why?
|
| Child | 147 | 2024 | 79806 | 0.530 |
Why?
|
| Absorbable Implants | 6 | 2006 | 345 | 0.530 |
Why?
|
| Transplantation, Autologous | 12 | 2018 | 2116 | 0.530 |
Why?
|
| Prosthesis Design | 19 | 2019 | 2135 | 0.530 |
Why?
|
| Vascular Resistance | 16 | 2009 | 933 | 0.520 |
Why?
|
| Exercise Tolerance | 3 | 2020 | 830 | 0.510 |
Why?
|
| Pulmonary Valve Stenosis | 7 | 2023 | 172 | 0.510 |
Why?
|
| Cross Circulation | 1 | 2015 | 11 | 0.500 |
Why?
|
| Monitoring, Intraoperative | 8 | 2009 | 942 | 0.500 |
Why?
|
| Extracellular Matrix | 11 | 2016 | 1726 | 0.500 |
Why?
|
| Parabiosis | 1 | 2015 | 64 | 0.490 |
Why?
|
| Follow-Up Studies | 102 | 2024 | 39261 | 0.480 |
Why?
|
| Myocardial Ischemia | 10 | 2015 | 2164 | 0.480 |
Why?
|
| Hospital Charges | 3 | 2015 | 359 | 0.480 |
Why?
|
| Pericardium | 3 | 2019 | 675 | 0.480 |
Why?
|
| Risk Assessment | 42 | 2022 | 24123 | 0.480 |
Why?
|
| Extracorporeal Circulation | 1 | 2015 | 182 | 0.470 |
Why?
|
| Mesenchymal Stem Cells | 7 | 2010 | 1634 | 0.470 |
Why?
|
| Polyglycolic Acid | 10 | 2010 | 405 | 0.470 |
Why?
|
| Cardiology | 4 | 2023 | 1723 | 0.460 |
Why?
|
| Pulmonary Veins | 18 | 2015 | 745 | 0.460 |
Why?
|
| Tissue Scaffolds | 7 | 2023 | 928 | 0.450 |
Why?
|
| Treatment Outcome | 109 | 2024 | 65017 | 0.450 |
Why?
|
| Ventricular Function, Left | 17 | 2014 | 3880 | 0.450 |
Why?
|
| Female | 222 | 2024 | 391270 | 0.440 |
Why?
|
| Retrospective Studies | 117 | 2024 | 80372 | 0.440 |
Why?
|
| Male | 218 | 2024 | 359744 | 0.440 |
Why?
|
| Consumer Advocacy | 1 | 2014 | 81 | 0.440 |
Why?
|
| Time Factors | 79 | 2019 | 40165 | 0.420 |
Why?
|
| Aortic Coarctation | 8 | 2018 | 282 | 0.420 |
Why?
|
| Diseases in Twins | 1 | 2014 | 447 | 0.410 |
Why?
|
| Hospitals, Pediatric | 5 | 2016 | 1854 | 0.410 |
Why?
|
| Survival Analysis | 42 | 2024 | 10182 | 0.410 |
Why?
|
| Double Outlet Right Ventricle | 9 | 2009 | 60 | 0.410 |
Why?
|
| Animals | 116 | 2023 | 167963 | 0.410 |
Why?
|
| Glycerol | 2 | 2014 | 276 | 0.400 |
Why?
|
| Foreign-Body Migration | 2 | 2011 | 218 | 0.400 |
Why?
|
| Cladribine | 1 | 2012 | 34 | 0.400 |
Why?
|
| Heart Injuries | 2 | 2011 | 208 | 0.400 |
Why?
|
| Cyanosis | 5 | 2000 | 86 | 0.390 |
Why?
|
| Adolescent | 103 | 2024 | 87810 | 0.390 |
Why?
|
| Insurance, Health | 3 | 2009 | 2501 | 0.390 |
Why?
|
| Survival Rate | 42 | 2021 | 12808 | 0.390 |
Why?
|
| Patient Advocacy | 1 | 2014 | 358 | 0.380 |
Why?
|
| United States | 53 | 2024 | 72461 | 0.370 |
Why?
|
| Health Care Reform | 3 | 2009 | 1245 | 0.370 |
Why?
|
| Echocardiography | 33 | 2020 | 4981 | 0.370 |
Why?
|
| Arteriovenous Malformations | 4 | 2010 | 397 | 0.370 |
Why?
|
| Graft Survival | 6 | 2024 | 3794 | 0.360 |
Why?
|
| Endocardial Cushion Defects | 5 | 2013 | 43 | 0.360 |
Why?
|
| Quality Indicators, Health Care | 4 | 2014 | 1824 | 0.360 |
Why?
|
| Hospital Costs | 6 | 2021 | 976 | 0.350 |
Why?
|
| Bioreactors | 8 | 2006 | 244 | 0.350 |
Why?
|
| Vidarabine | 2 | 2011 | 336 | 0.350 |
Why?
|
| Septal Occluder Device | 1 | 2011 | 126 | 0.350 |
Why?
|
| Muscle, Smooth, Vascular | 8 | 2016 | 1485 | 0.350 |
Why?
|
| Length of Stay | 18 | 2021 | 6479 | 0.350 |
Why?
|
| Cell Culture Techniques | 7 | 2011 | 1664 | 0.350 |
Why?
|
| Myocardium | 18 | 2002 | 4700 | 0.350 |
Why?
|
| Busulfan | 1 | 2011 | 258 | 0.350 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2012 | 169 | 0.350 |
Why?
|
| Aorta | 13 | 2013 | 2039 | 0.340 |
Why?
|
| Nitroglycerin | 4 | 2003 | 329 | 0.340 |
Why?
|
| Lactic Acid | 7 | 2010 | 1134 | 0.340 |
Why?
|
| Sinus of Valsalva | 1 | 2010 | 60 | 0.340 |
Why?
|
| Preoperative Care | 11 | 2014 | 2256 | 0.330 |
Why?
|
| Health Care Rationing | 2 | 2012 | 435 | 0.330 |
Why?
|
| Phenol | 1 | 2009 | 44 | 0.330 |
Why?
|
| Spinal Diseases | 3 | 2018 | 559 | 0.330 |
Why?
|
| Antilymphocyte Serum | 1 | 2011 | 482 | 0.330 |
Why?
|
| Calcinosis | 2 | 2015 | 1476 | 0.320 |
Why?
|
| Surgical Flaps | 2 | 2016 | 1669 | 0.310 |
Why?
|
| Cells, Cultured | 28 | 2016 | 18957 | 0.310 |
Why?
|
| Specialization | 4 | 2013 | 778 | 0.310 |
Why?
|
| Vena Cava, Superior | 10 | 2008 | 197 | 0.310 |
Why?
|
| Prostheses and Implants | 10 | 2009 | 1273 | 0.310 |
Why?
|
| Relative Value Scales | 4 | 2014 | 86 | 0.300 |
Why?
|
| Graft Rejection | 7 | 2024 | 4426 | 0.300 |
Why?
|
| Kaplan-Meier Estimate | 17 | 2021 | 6544 | 0.300 |
Why?
|
| Pulmonary Circulation | 11 | 2011 | 743 | 0.300 |
Why?
|
| Age Factors | 23 | 2019 | 18416 | 0.300 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 9 | 2020 | 5649 | 0.300 |
Why?
|
| Cardiovascular System | 3 | 2012 | 850 | 0.300 |
Why?
|
| Stress, Mechanical | 11 | 2016 | 1666 | 0.290 |
Why?
|
| Government Regulation | 2 | 2009 | 525 | 0.290 |
Why?
|
| Models, Statistical | 4 | 2019 | 5075 | 0.290 |
Why?
|
| Nitric Oxide | 8 | 2005 | 2141 | 0.290 |
Why?
|
| Hematologic Neoplasms | 3 | 2020 | 1895 | 0.290 |
Why?
|
| Microscopy, Electron, Scanning | 14 | 2018 | 941 | 0.290 |
Why?
|
| Mitral Valve Insufficiency | 6 | 2017 | 1419 | 0.290 |
Why?
|
| Databases as Topic | 4 | 2014 | 474 | 0.280 |
Why?
|
| Oxygen Consumption | 13 | 2002 | 1843 | 0.280 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2008 | 225 | 0.280 |
Why?
|
| Bayes Theorem | 4 | 2022 | 2326 | 0.280 |
Why?
|
| Aortic Aneurysm | 2 | 2010 | 648 | 0.280 |
Why?
|
| Transplantation Conditioning | 2 | 2011 | 1588 | 0.280 |
Why?
|
| Interleukin-3 | 1 | 2008 | 425 | 0.270 |
Why?
|
| Thoracotomy | 2 | 2018 | 363 | 0.270 |
Why?
|
| Health Policy | 2 | 2009 | 2677 | 0.270 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 1 | 2008 | 263 | 0.270 |
Why?
|
| Antigens, CD34 | 2 | 2008 | 653 | 0.270 |
Why?
|
| Ethics, Medical | 2 | 2023 | 783 | 0.270 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 2 | 2008 | 498 | 0.260 |
Why?
|
| Lidocaine | 1 | 2009 | 538 | 0.260 |
Why?
|
| Adult | 103 | 2023 | 219994 | 0.260 |
Why?
|
| Quality Assurance, Health Care | 5 | 2019 | 2176 | 0.260 |
Why?
|
| Collagen | 14 | 2016 | 2636 | 0.260 |
Why?
|
| Endothelins | 2 | 1996 | 127 | 0.260 |
Why?
|
| Clinical Competence | 7 | 2016 | 4783 | 0.250 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 3 | 2015 | 685 | 0.250 |
Why?
|
| Retroviridae | 2 | 2010 | 850 | 0.250 |
Why?
|
| Reimbursement Mechanisms | 4 | 2017 | 664 | 0.250 |
Why?
|
| Polyethylene Terephthalates | 5 | 2001 | 115 | 0.250 |
Why?
|
| Arrhythmias, Cardiac | 12 | 2020 | 2255 | 0.250 |
Why?
|
| Quality Improvement | 8 | 2019 | 3836 | 0.250 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2008 | 629 | 0.240 |
Why?
|
| Physical Therapy Modalities | 2 | 2008 | 536 | 0.240 |
Why?
|
| Health Resources | 3 | 2020 | 935 | 0.240 |
Why?
|
| Anastomosis, Surgical | 13 | 2008 | 983 | 0.230 |
Why?
|
| Transplantation, Homologous | 7 | 2017 | 4810 | 0.230 |
Why?
|
| Luminescent Proteins | 1 | 2007 | 835 | 0.230 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2014 | 1717 | 0.230 |
Why?
|
| Cause of Death | 10 | 2019 | 3725 | 0.230 |
Why?
|
| Risk Factors | 64 | 2023 | 74359 | 0.230 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2007 | 829 | 0.230 |
Why?
|
| Brachial Artery | 1 | 2005 | 366 | 0.230 |
Why?
|
| Troponin T | 2 | 2008 | 774 | 0.230 |
Why?
|
| Blood Vessel Prosthesis Implantation | 7 | 2014 | 1446 | 0.220 |
Why?
|
| Hemodilution | 4 | 2009 | 120 | 0.220 |
Why?
|
| Sex Factors | 6 | 2016 | 10547 | 0.220 |
Why?
|
| Cardiology Service, Hospital | 2 | 2016 | 242 | 0.220 |
Why?
|
| Remission Induction | 8 | 2020 | 2392 | 0.220 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2010 | 698 | 0.220 |
Why?
|
| Social Security | 3 | 2013 | 101 | 0.220 |
Why?
|
| Heart Atria | 15 | 2012 | 1346 | 0.220 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2008 | 1375 | 0.210 |
Why?
|
| Bone Marrow Cells | 3 | 2011 | 2414 | 0.210 |
Why?
|
| Adenosine | 3 | 1998 | 834 | 0.210 |
Why?
|
| Green Fluorescent Proteins | 2 | 2010 | 2057 | 0.210 |
Why?
|
| Glucose | 9 | 2023 | 4351 | 0.200 |
Why?
|
| Tricuspid Valve | 10 | 2011 | 409 | 0.200 |
Why?
|
| Physician's Role | 1 | 2009 | 918 | 0.200 |
Why?
|
| Hospitals | 4 | 2022 | 3928 | 0.200 |
Why?
|
| Membranes, Artificial | 2 | 2000 | 367 | 0.200 |
Why?
|
| Persuasive Communication | 1 | 2022 | 58 | 0.200 |
Why?
|
| Heart Septum | 8 | 2007 | 303 | 0.200 |
Why?
|
| Low Back Pain | 2 | 2008 | 979 | 0.200 |
Why?
|
| Risk Adjustment | 2 | 2017 | 601 | 0.190 |
Why?
|
| Delivery of Health Care | 4 | 2009 | 5325 | 0.190 |
Why?
|
| Leukemia, Myeloid | 1 | 2005 | 695 | 0.190 |
Why?
|
| Myocardial Contraction | 7 | 2000 | 1516 | 0.190 |
Why?
|
| United States Food and Drug Administration | 3 | 2009 | 1677 | 0.190 |
Why?
|
| Leukemia, Promyelocytic, Acute | 2 | 2017 | 251 | 0.190 |
Why?
|
| Oligosaccharides | 2 | 2000 | 405 | 0.190 |
Why?
|
| Diffusion of Innovation | 3 | 2016 | 730 | 0.190 |
Why?
|
| Young Adult | 28 | 2020 | 58741 | 0.190 |
Why?
|
| Collateral Circulation | 3 | 2018 | 292 | 0.190 |
Why?
|
| Mitral Valve | 11 | 2019 | 1486 | 0.180 |
Why?
|
| Exercise Therapy | 1 | 2008 | 919 | 0.180 |
Why?
|
| Boston | 12 | 2016 | 9280 | 0.180 |
Why?
|
| Coronary Vessels | 10 | 2000 | 3112 | 0.180 |
Why?
|
| Aortic Diseases | 2 | 2023 | 736 | 0.180 |
Why?
|
| History, 20th Century | 6 | 2016 | 2773 | 0.180 |
Why?
|
| Analysis of Variance | 16 | 2006 | 6238 | 0.180 |
Why?
|
| Ventricular Dysfunction, Left | 5 | 2013 | 2128 | 0.180 |
Why?
|
| Plasma Substitutes | 2 | 2008 | 57 | 0.170 |
Why?
|
| Models, Organizational | 1 | 2003 | 545 | 0.170 |
Why?
|
| Selectins | 2 | 1997 | 101 | 0.170 |
Why?
|
| Polyglactin 910 | 1 | 1999 | 55 | 0.170 |
Why?
|
| Mesoderm | 1 | 2003 | 672 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 6 | 2010 | 9185 | 0.170 |
Why?
|
| Clinical Audit | 1 | 2019 | 30 | 0.170 |
Why?
|
| Cardiac Pacing, Artificial | 6 | 2012 | 866 | 0.170 |
Why?
|
| Weight-Bearing | 1 | 2002 | 518 | 0.170 |
Why?
|
| Pacemaker, Artificial | 8 | 2013 | 815 | 0.170 |
Why?
|
| Tracheal Stenosis | 1 | 2021 | 226 | 0.170 |
Why?
|
| Hematocrit | 4 | 2009 | 629 | 0.170 |
Why?
|
| Codes of Ethics | 1 | 2019 | 61 | 0.160 |
Why?
|
| Patient Selection | 5 | 2017 | 4283 | 0.160 |
Why?
|
| Chordae Tendineae | 1 | 2019 | 39 | 0.160 |
Why?
|
| Tricuspid Atresia | 2 | 2013 | 37 | 0.160 |
Why?
|
| Dilatation, Pathologic | 5 | 2023 | 527 | 0.160 |
Why?
|
| Fistula | 2 | 2012 | 214 | 0.160 |
Why?
|
| Medicine | 1 | 2007 | 943 | 0.160 |
Why?
|
| Industry | 1 | 2021 | 361 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 3735 | 0.160 |
Why?
|
| Prognosis | 25 | 2023 | 29658 | 0.160 |
Why?
|
| Elastomers | 4 | 2016 | 69 | 0.160 |
Why?
|
| P-Selectin | 2 | 1998 | 599 | 0.160 |
Why?
|
| Cohort Studies | 23 | 2019 | 41335 | 0.160 |
Why?
|
| Materials Testing | 7 | 2019 | 862 | 0.160 |
Why?
|
| Cattle | 6 | 2023 | 3847 | 0.160 |
Why?
|
| Postoperative Care | 7 | 2014 | 1479 | 0.160 |
Why?
|
| Physical Exertion | 4 | 2014 | 662 | 0.160 |
Why?
|
| Awards and Prizes | 1 | 2003 | 359 | 0.160 |
Why?
|
| Hemofiltration | 1 | 1998 | 59 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 1 | 2006 | 1959 | 0.160 |
Why?
|
| Fee Schedules | 4 | 2013 | 85 | 0.150 |
Why?
|
| Escherichia coli O157 | 1 | 2018 | 53 | 0.150 |
Why?
|
| Thermodilution | 2 | 2009 | 51 | 0.150 |
Why?
|
| Cell Communication | 3 | 2015 | 1653 | 0.150 |
Why?
|
| Arteriovenous Shunt, Surgical | 6 | 2008 | 294 | 0.150 |
Why?
|
| Chromosome Aberrations | 3 | 2016 | 1764 | 0.150 |
Why?
|
| Middle Aged | 48 | 2020 | 220352 | 0.150 |
Why?
|
| Swine | 8 | 2019 | 5899 | 0.150 |
Why?
|
| Cooperative Behavior | 2 | 2019 | 1500 | 0.150 |
Why?
|
| Phenotype | 7 | 2020 | 16546 | 0.150 |
Why?
|
| Critical Pathways | 2 | 2018 | 475 | 0.150 |
Why?
|
| Postoperative Period | 12 | 2018 | 1818 | 0.150 |
Why?
|
| Hemolytic-Uremic Syndrome | 1 | 2018 | 106 | 0.150 |
Why?
|
| Ultrasonography | 12 | 2014 | 5961 | 0.150 |
Why?
|
| Aged | 37 | 2022 | 169152 | 0.150 |
Why?
|
| Developmental Disabilities | 4 | 2008 | 1504 | 0.150 |
Why?
|
| Physical Fitness | 1 | 2002 | 732 | 0.150 |
Why?
|
| Blood | 4 | 1994 | 586 | 0.150 |
Why?
|
| Specialties, Surgical | 1 | 2022 | 388 | 0.150 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2017 | 508 | 0.150 |
Why?
|
| Organ Preservation Solutions | 1 | 2018 | 100 | 0.150 |
Why?
|
| Tissue Preservation | 1 | 2018 | 174 | 0.140 |
Why?
|
| Cold Temperature | 2 | 1998 | 780 | 0.140 |
Why?
|
| Evidence-Based Medicine | 2 | 2018 | 3696 | 0.140 |
Why?
|
| Umbilical Veins | 1 | 2018 | 426 | 0.140 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 1999 | 397 | 0.140 |
Why?
|
| Genetic Vectors | 1 | 2007 | 3380 | 0.140 |
Why?
|
| Electronic Health Records | 1 | 2014 | 4775 | 0.140 |
Why?
|
| Calcium | 4 | 1994 | 5725 | 0.140 |
Why?
|
| Aorta, Abdominal | 1 | 1999 | 625 | 0.140 |
Why?
|
| Current Procedural Terminology | 2 | 2014 | 90 | 0.140 |
Why?
|
| Organizational Objectives | 2 | 2009 | 428 | 0.140 |
Why?
|
| Arsenicals | 1 | 2017 | 117 | 0.140 |
Why?
|
| Heart Failure | 7 | 2014 | 11847 | 0.140 |
Why?
|
| Aged, 80 and over | 20 | 2017 | 58995 | 0.140 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2014 | 1628 | 0.130 |
Why?
|
| Terminology as Topic | 3 | 2014 | 1535 | 0.130 |
Why?
|
| Patient Discharge | 2 | 2023 | 3476 | 0.130 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2014 | 1572 | 0.130 |
Why?
|
| Vasodilation | 1 | 2000 | 962 | 0.130 |
Why?
|
| Logistic Models | 17 | 2019 | 13314 | 0.130 |
Why?
|
| Chromosome Disorders | 1 | 2019 | 499 | 0.130 |
Why?
|
| Carotid Arteries | 2 | 2000 | 951 | 0.130 |
Why?
|
| Lung | 8 | 2003 | 9994 | 0.130 |
Why?
|
| Medicare | 7 | 2022 | 6786 | 0.130 |
Why?
|
| Proportional Hazards Models | 16 | 2021 | 12531 | 0.130 |
Why?
|
| Tachycardia, Supraventricular | 2 | 2012 | 274 | 0.130 |
Why?
|
| Employee Performance Appraisal | 1 | 2016 | 86 | 0.130 |
Why?
|
| Leukocytes | 2 | 2008 | 2026 | 0.130 |
Why?
|
| Fibroblasts | 6 | 2007 | 4090 | 0.130 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2017 | 143 | 0.130 |
Why?
|
| Porosity | 6 | 2005 | 349 | 0.130 |
Why?
|
| Computer-Aided Design | 1 | 2017 | 302 | 0.130 |
Why?
|
| Tumor Lysis Syndrome | 1 | 2015 | 38 | 0.130 |
Why?
|
| Probability | 11 | 2013 | 2475 | 0.130 |
Why?
|
| Blood Vessels | 3 | 2004 | 1112 | 0.130 |
Why?
|
| Acetylcholine | 6 | 2000 | 629 | 0.130 |
Why?
|
| Peptide Fragments | 1 | 2008 | 5125 | 0.130 |
Why?
|
| Health Services Accessibility | 2 | 2015 | 5397 | 0.130 |
Why?
|
| Oxides | 1 | 2017 | 401 | 0.120 |
Why?
|
| Mobiluncus | 1 | 1994 | 1 | 0.120 |
Why?
|
| Informed Consent | 1 | 2022 | 1005 | 0.120 |
Why?
|
| Spine | 1 | 2002 | 1111 | 0.120 |
Why?
|
| Socioeconomic Factors | 1 | 2009 | 7806 | 0.120 |
Why?
|
| Acidosis, Respiratory | 1 | 1994 | 38 | 0.120 |
Why?
|
| Multiple Birth Offspring | 1 | 2014 | 22 | 0.120 |
Why?
|
| Multivariate Analysis | 15 | 2019 | 12159 | 0.120 |
Why?
|
| Bacteroidaceae Infections | 1 | 1994 | 31 | 0.120 |
Why?
|
| Hepatic Veins | 2 | 2010 | 112 | 0.120 |
Why?
|
| Macrophage-1 Antigen | 1 | 1995 | 286 | 0.120 |
Why?
|
| Thromboembolism | 2 | 2013 | 1017 | 0.120 |
Why?
|
| Chlamydia trachomatis | 2 | 1994 | 238 | 0.120 |
Why?
|
| Immunophenotyping | 3 | 2015 | 1871 | 0.120 |
Why?
|
| Transplantation, Heterologous | 1 | 2003 | 2379 | 0.120 |
Why?
|
| Disclosure | 2 | 2012 | 738 | 0.120 |
Why?
|
| Intensive Care Units | 3 | 2019 | 3736 | 0.120 |
Why?
|
| Angioplasty, Balloon, Coronary | 2 | 2012 | 1880 | 0.120 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2014 | 646 | 0.120 |
Why?
|
| Escherichia coli Infections | 1 | 2018 | 523 | 0.120 |
Why?
|
| Quality of Health Care | 4 | 2017 | 4360 | 0.110 |
Why?
|
| Decanoates | 1 | 2014 | 55 | 0.110 |
Why?
|
| Recurrence | 8 | 2020 | 8482 | 0.110 |
Why?
|
| Fertilization in Vitro | 5 | 1999 | 1292 | 0.110 |
Why?
|
| Milrinone | 1 | 2014 | 86 | 0.110 |
Why?
|
| Obesity | 10 | 2009 | 12922 | 0.110 |
Why?
|
| Allopurinol | 1 | 2015 | 198 | 0.110 |
Why?
|
| Budgets | 1 | 2015 | 230 | 0.110 |
Why?
|
| Radiography, Thoracic | 1 | 2020 | 1296 | 0.110 |
Why?
|
| Cell Transdifferentiation | 1 | 2015 | 185 | 0.110 |
Why?
|
| Cell Transplantation | 4 | 2000 | 472 | 0.110 |
Why?
|
| Gout Suppressants | 1 | 2015 | 177 | 0.110 |
Why?
|
| Morbidity | 7 | 2019 | 1765 | 0.110 |
Why?
|
| Pericardial Effusion | 2 | 2011 | 247 | 0.110 |
Why?
|
| Schools, Medical | 1 | 2020 | 878 | 0.110 |
Why?
|
| Growth | 3 | 1994 | 365 | 0.110 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2013 | 321 | 0.110 |
Why?
|
| Lymphocyte Depletion | 1 | 1995 | 602 | 0.110 |
Why?
|
| Extracorporeal Membrane Oxygenation | 7 | 2019 | 1459 | 0.110 |
Why?
|
| Myofibroblasts | 1 | 2015 | 207 | 0.110 |
Why?
|
| Antigens, CD | 3 | 2004 | 4000 | 0.110 |
Why?
|
| Receptors, Leukocyte-Adhesion | 1 | 1992 | 52 | 0.110 |
Why?
|
| Hypercapnia | 1 | 1994 | 261 | 0.110 |
Why?
|
| Program Development | 2 | 2016 | 1297 | 0.110 |
Why?
|
| Twins | 1 | 2014 | 339 | 0.110 |
Why?
|
| Life Tables | 4 | 2006 | 365 | 0.110 |
Why?
|
| Intercellular Adhesion Molecule-1 | 5 | 2003 | 1126 | 0.100 |
Why?
|
| Acidosis | 1 | 1994 | 268 | 0.100 |
Why?
|
| Catheterization | 7 | 2004 | 1432 | 0.100 |
Why?
|
| Atrial Natriuretic Factor | 2 | 2008 | 350 | 0.100 |
Why?
|
| Anesthetics, Local | 2 | 2010 | 1001 | 0.100 |
Why?
|
| Angiography | 4 | 2018 | 1605 | 0.100 |
Why?
|
| Thrombosis | 4 | 2023 | 3052 | 0.100 |
Why?
|
| Echocardiography, Doppler | 5 | 2000 | 901 | 0.100 |
Why?
|
| Health Care Costs | 3 | 2012 | 3258 | 0.100 |
Why?
|
| Dyspnea | 1 | 2020 | 1352 | 0.100 |
Why?
|
| Recovery of Function | 4 | 2018 | 2985 | 0.100 |
Why?
|
| Tachycardia, Reciprocating | 1 | 2012 | 15 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2017 | 11712 | 0.100 |
Why?
|
| Inflammation | 3 | 2023 | 10756 | 0.100 |
Why?
|
| Organ Preservation | 1 | 1995 | 379 | 0.100 |
Why?
|
| Risk | 8 | 2017 | 9631 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2015 | 608 | 0.100 |
Why?
|
| Heart Diseases | 5 | 2012 | 2809 | 0.100 |
Why?
|
| Occupational Exposure | 2 | 2014 | 1809 | 0.100 |
Why?
|
| Eating | 8 | 1991 | 1539 | 0.100 |
Why?
|
| Peroxidase | 3 | 2000 | 605 | 0.100 |
Why?
|
| Equipment Failure Analysis | 4 | 2012 | 848 | 0.100 |
Why?
|
| Reproducibility of Results | 11 | 2017 | 20080 | 0.100 |
Why?
|
| Education, Medical, Continuing | 3 | 2019 | 830 | 0.100 |
Why?
|
| Atrioventricular Block | 1 | 2013 | 121 | 0.100 |
Why?
|
| Malondialdehyde | 2 | 2003 | 112 | 0.100 |
Why?
|
| Cardiovascular Diseases | 5 | 2012 | 15757 | 0.100 |
Why?
|
| Patient Care Team | 3 | 2016 | 2511 | 0.100 |
Why?
|
| Mechanical Phenomena | 1 | 2013 | 140 | 0.100 |
Why?
|
| Dilatation | 2 | 2023 | 307 | 0.100 |
Why?
|
| Semen | 3 | 1999 | 346 | 0.100 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2013 | 218 | 0.100 |
Why?
|
| Ethylene Oxide | 1 | 1991 | 28 | 0.100 |
Why?
|
| DNA Copy Number Variations | 1 | 2020 | 2013 | 0.100 |
Why?
|
| Data Collection | 5 | 2014 | 3315 | 0.100 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 2018 | 1014 | 0.090 |
Why?
|
| Disease Models, Animal | 12 | 2017 | 18137 | 0.090 |
Why?
|
| Azygos Vein | 1 | 2010 | 19 | 0.090 |
Why?
|
| Hospital Administration | 1 | 2015 | 355 | 0.090 |
Why?
|
| Mandatory Reporting | 1 | 2012 | 124 | 0.090 |
Why?
|
| Prosthesis Implantation | 2 | 2013 | 594 | 0.090 |
Why?
|
| Disability Evaluation | 1 | 2018 | 1826 | 0.090 |
Why?
|
| Lung Compliance | 2 | 2003 | 201 | 0.090 |
Why?
|
| Nitrites | 2 | 2003 | 159 | 0.090 |
Why?
|
| Forecasting | 4 | 2015 | 2932 | 0.090 |
Why?
|
| Cost-Benefit Analysis | 5 | 2017 | 5508 | 0.090 |
Why?
|
| Models, Cardiovascular | 2 | 2013 | 978 | 0.090 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2020 | 1066 | 0.090 |
Why?
|
| Ebstein Anomaly | 1 | 2011 | 101 | 0.090 |
Why?
|
| Glycosaminoglycans | 2 | 2006 | 605 | 0.090 |
Why?
|
| Stem Cell Transplantation | 2 | 2011 | 1599 | 0.090 |
Why?
|
| Interdisciplinary Communication | 1 | 2016 | 934 | 0.090 |
Why?
|
| Delphi Technique | 3 | 2018 | 829 | 0.090 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2014 | 854 | 0.090 |
Why?
|
| Incidence | 13 | 2018 | 21392 | 0.090 |
Why?
|
| Cryopreservation | 1 | 1995 | 717 | 0.090 |
Why?
|
| History, 21st Century | 1 | 2016 | 1575 | 0.090 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 2 | 2009 | 82 | 0.090 |
Why?
|
| Sinoatrial Node | 3 | 2001 | 99 | 0.090 |
Why?
|
| Feasibility Studies | 6 | 2017 | 5201 | 0.090 |
Why?
|
| Cell Division | 5 | 2006 | 4463 | 0.090 |
Why?
|
| Prospective Studies | 23 | 2017 | 54303 | 0.090 |
Why?
|
| Polysaccharides | 1 | 1996 | 1016 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2002 | 2502 | 0.090 |
Why?
|
| Tricuspid Valve Insufficiency | 2 | 2011 | 355 | 0.090 |
Why?
|
| Accessory Atrioventricular Bundle | 1 | 2010 | 58 | 0.090 |
Why?
|
| Heart Block | 4 | 2000 | 392 | 0.090 |
Why?
|
| Curriculum | 1 | 2023 | 3718 | 0.090 |
Why?
|
| Nitrates | 2 | 2003 | 264 | 0.090 |
Why?
|
| Cell Tracking | 1 | 2011 | 138 | 0.080 |
Why?
|
| Cell Differentiation | 5 | 2015 | 11481 | 0.080 |
Why?
|
| Biomedical Research | 2 | 2024 | 3426 | 0.080 |
Why?
|
| Wolff-Parkinson-White Syndrome | 1 | 2010 | 116 | 0.080 |
Why?
|
| Biodegradation, Environmental | 2 | 2000 | 218 | 0.080 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 546 | 0.080 |
Why?
|
| Protein-Losing Enteropathies | 2 | 2001 | 45 | 0.080 |
Why?
|
| Leukemia, Myeloid, Acute | 2 | 2016 | 3602 | 0.080 |
Why?
|
| Bronchial Fistula | 1 | 1989 | 83 | 0.080 |
Why?
|
| Lymphatic System | 1 | 1991 | 254 | 0.080 |
Why?
|
| Norwood Procedures | 1 | 2011 | 192 | 0.080 |
Why?
|
| Gene Expression Regulation | 6 | 2015 | 11903 | 0.080 |
Why?
|
| Coronary Artery Disease | 2 | 2008 | 6659 | 0.080 |
Why?
|
| Sacroiliac Joint | 1 | 2009 | 57 | 0.080 |
Why?
|
| Neoplasms, Second Primary | 1 | 2017 | 1056 | 0.080 |
Why?
|
| Education, Medical, Graduate | 3 | 2016 | 2363 | 0.080 |
Why?
|
| Potassium Compounds | 1 | 1988 | 42 | 0.080 |
Why?
|
| Vascular Diseases | 2 | 2015 | 1182 | 0.080 |
Why?
|
| Lumbar Vertebrae | 2 | 2009 | 1868 | 0.080 |
Why?
|
| Ferric Compounds | 1 | 2011 | 377 | 0.080 |
Why?
|
| Lipid Peroxides | 2 | 1998 | 74 | 0.080 |
Why?
|
| Antibodies, Neoplasm | 1 | 2010 | 280 | 0.080 |
Why?
|
| Marijuana Smoking | 1 | 2012 | 257 | 0.080 |
Why?
|
| Qualitative Research | 1 | 2019 | 2963 | 0.080 |
Why?
|
| Cerebrovascular Disorders | 2 | 1995 | 1501 | 0.080 |
Why?
|
| Pseudomonas Infections | 1 | 2013 | 623 | 0.080 |
Why?
|
| Enoximone | 1 | 2008 | 9 | 0.080 |
Why?
|
| Foramen Ovale, Patent | 1 | 2011 | 214 | 0.080 |
Why?
|
| Aspirin | 3 | 2013 | 3364 | 0.080 |
Why?
|
| Multiple Sclerosis | 1 | 2023 | 3204 | 0.080 |
Why?
|
| Injections, Spinal | 1 | 2009 | 316 | 0.080 |
Why?
|
| Osteogenesis | 1 | 2015 | 1271 | 0.080 |
Why?
|
| Severity of Illness Index | 9 | 2012 | 15840 | 0.080 |
Why?
|
| Atrial Flutter | 2 | 2003 | 258 | 0.080 |
Why?
|
| Equipment Failure | 2 | 2009 | 577 | 0.080 |
Why?
|
| Medical Record Linkage | 1 | 2010 | 288 | 0.080 |
Why?
|
| Truncus Arteriosus | 2 | 2023 | 22 | 0.080 |
Why?
|
| Perfusion | 3 | 2006 | 1376 | 0.080 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2008 | 105 | 0.080 |
Why?
|
| Physicians | 2 | 2017 | 4591 | 0.080 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2015 | 5643 | 0.080 |
Why?
|
| Filgrastim | 1 | 2008 | 132 | 0.070 |
Why?
|
| Neutrophils | 4 | 2000 | 3767 | 0.070 |
Why?
|
| Injections, Intra-Articular | 1 | 2009 | 279 | 0.070 |
Why?
|
| Work Capacity Evaluation | 1 | 2007 | 45 | 0.070 |
Why?
|
| Vascular Patency | 3 | 2002 | 901 | 0.070 |
Why?
|
| Equipment Design | 8 | 2019 | 3520 | 0.070 |
Why?
|
| Leukapheresis | 1 | 2008 | 134 | 0.070 |
Why?
|
| Drug Therapy, Combination | 4 | 2014 | 6498 | 0.070 |
Why?
|
| Dipyridamole | 2 | 1981 | 143 | 0.070 |
Why?
|
| Anemia | 1 | 2017 | 1511 | 0.070 |
Why?
|
| Contrast Media | 3 | 2011 | 5305 | 0.070 |
Why?
|
| Propanolamines | 1 | 2008 | 162 | 0.070 |
Why?
|
| Disease Progression | 5 | 2014 | 13502 | 0.070 |
Why?
|
| Liver Function Tests | 1 | 2009 | 524 | 0.070 |
Why?
|
| Radial Artery | 1 | 2009 | 196 | 0.070 |
Why?
|
| National Health Insurance, United States | 1 | 2007 | 100 | 0.070 |
Why?
|
| Benzamides | 1 | 2013 | 1369 | 0.070 |
Why?
|
| Ventricular Function | 4 | 1999 | 408 | 0.070 |
Why?
|
| Aortic Arch Syndromes | 1 | 2007 | 19 | 0.070 |
Why?
|
| Endoscopy | 1 | 2017 | 1838 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2009 | 796 | 0.070 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2013 | 553 | 0.070 |
Why?
|
| Liver | 2 | 2000 | 7509 | 0.070 |
Why?
|
| Cardiomyopathies | 2 | 2024 | 1952 | 0.070 |
Why?
|
| Mortality | 3 | 2021 | 2916 | 0.070 |
Why?
|
| Patient Education as Topic | 2 | 2010 | 2315 | 0.070 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2009 | 1547 | 0.070 |
Why?
|
| Myelodysplastic Syndromes | 1 | 2017 | 1394 | 0.070 |
Why?
|
| Health Facilities | 1 | 2012 | 578 | 0.070 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2008 | 214 | 0.070 |
Why?
|
| Coronary Disease | 3 | 2012 | 5990 | 0.070 |
Why?
|
| Oximetry | 2 | 2009 | 461 | 0.070 |
Why?
|
| Swine, Miniature | 1 | 2009 | 959 | 0.070 |
Why?
|
| Critical Care | 1 | 2019 | 2699 | 0.070 |
Why?
|
| Oxygen | 6 | 2009 | 4193 | 0.070 |
Why?
|
| Students, Medical | 1 | 2020 | 1927 | 0.070 |
Why?
|
| Antigens, Differentiation | 1 | 2010 | 911 | 0.070 |
Why?
|
| E-Selectin | 4 | 1996 | 576 | 0.070 |
Why?
|
| Mechanotransduction, Cellular | 3 | 2009 | 530 | 0.070 |
Why?
|
| Statistics, Nonparametric | 6 | 2013 | 2852 | 0.070 |
Why?
|
| Chi-Square Distribution | 4 | 2014 | 3465 | 0.070 |
Why?
|
| Ligaments, Articular | 1 | 2009 | 300 | 0.070 |
Why?
|
| Resuscitation | 2 | 2008 | 661 | 0.070 |
Why?
|
| Atrial Appendage | 1 | 2010 | 292 | 0.070 |
Why?
|
| Sickness Impact Profile | 1 | 2007 | 298 | 0.070 |
Why?
|
| Random Allocation | 2 | 2009 | 2394 | 0.070 |
Why?
|
| Anthozoa | 1 | 2007 | 65 | 0.070 |
Why?
|
| Drug Evaluation, Preclinical | 3 | 1996 | 1347 | 0.070 |
Why?
|
| Antibodies | 2 | 2013 | 2421 | 0.070 |
Why?
|
| Device Removal | 1 | 2011 | 636 | 0.070 |
Why?
|
| Patient Readmission | 2 | 2014 | 3323 | 0.070 |
Why?
|
| Health Expenditures | 2 | 2009 | 2362 | 0.070 |
Why?
|
| Muscle Contraction | 1 | 1991 | 1201 | 0.070 |
Why?
|
| Nitrous Oxide | 1 | 1986 | 166 | 0.070 |
Why?
|
| Constriction, Pathologic | 6 | 2015 | 1098 | 0.070 |
Why?
|
| Aftercare | 2 | 2023 | 916 | 0.060 |
Why?
|
| Education, Medical | 1 | 2017 | 1727 | 0.060 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 2622 | 0.060 |
Why?
|
| Actins | 3 | 2014 | 2049 | 0.060 |
Why?
|
| Aging | 2 | 2013 | 8651 | 0.060 |
Why?
|
| Warfarin | 2 | 2013 | 1518 | 0.060 |
Why?
|
| Nerve Fibers | 1 | 2009 | 708 | 0.060 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2013 | 1276 | 0.060 |
Why?
|
| International Cooperation | 2 | 2003 | 1433 | 0.060 |
Why?
|
| Sensitivity and Specificity | 6 | 2018 | 14660 | 0.060 |
Why?
|
| Physical Stimulation | 2 | 2005 | 518 | 0.060 |
Why?
|
| Exercise Test | 3 | 2011 | 2128 | 0.060 |
Why?
|
| Narcotic Antagonists | 1 | 2010 | 583 | 0.060 |
Why?
|
| Vena Cava, Inferior | 3 | 2005 | 458 | 0.060 |
Why?
|
| Finite Element Analysis | 3 | 2013 | 428 | 0.060 |
Why?
|
| Tensile Strength | 2 | 2014 | 330 | 0.060 |
Why?
|
| Heart Function Tests | 2 | 2008 | 319 | 0.060 |
Why?
|
| Vasculitis | 1 | 2009 | 523 | 0.060 |
Why?
|
| Jugular Veins | 3 | 2023 | 211 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2020 | 36290 | 0.060 |
Why?
|
| Daunorubicin | 1 | 2005 | 156 | 0.060 |
Why?
|
| Mitoxantrone | 1 | 2005 | 149 | 0.060 |
Why?
|
| Fibrosis | 2 | 2009 | 2042 | 0.060 |
Why?
|
| Genetic Markers | 1 | 1991 | 2608 | 0.060 |
Why?
|
| Social Responsibility | 1 | 2007 | 386 | 0.060 |
Why?
|
| Necrosis | 1 | 2009 | 1612 | 0.060 |
Why?
|
| Lipids | 1 | 2016 | 3336 | 0.060 |
Why?
|
| Ultrasonics | 1 | 2006 | 207 | 0.060 |
Why?
|
| Carbon Dioxide | 3 | 2002 | 1146 | 0.060 |
Why?
|
| Frail Elderly | 1 | 2010 | 752 | 0.060 |
Why?
|
| Neoplasm, Residual | 1 | 2009 | 1007 | 0.060 |
Why?
|
| Athletes | 1 | 2012 | 1125 | 0.060 |
Why?
|
| Electrocardiography | 10 | 2012 | 6414 | 0.060 |
Why?
|
| Ceramics | 3 | 2000 | 113 | 0.060 |
Why?
|
| Interferon-gamma | 1 | 1993 | 3157 | 0.060 |
Why?
|
| Survivors | 2 | 2012 | 2375 | 0.060 |
Why?
|
| Predictive Value of Tests | 9 | 2014 | 15289 | 0.060 |
Why?
|
| Pamphlets | 1 | 2004 | 71 | 0.060 |
Why?
|
| Spinal Injuries | 1 | 2007 | 300 | 0.060 |
Why?
|
| Body Water | 2 | 1998 | 341 | 0.060 |
Why?
|
| Hemorheology | 1 | 2004 | 144 | 0.060 |
Why?
|
| Slovakia | 1 | 2003 | 8 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2014 | 2919 | 0.060 |
Why?
|
| Tachycardia, Ectopic Atrial | 2 | 1996 | 65 | 0.060 |
Why?
|
| Slovenia | 1 | 2003 | 21 | 0.060 |
Why?
|
| Electrocardiography, Ambulatory | 4 | 2011 | 578 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 2013 | 1274 | 0.060 |
Why?
|
| Humerus | 1 | 2006 | 269 | 0.060 |
Why?
|
| Tachycardia | 2 | 2003 | 602 | 0.060 |
Why?
|
| Odds Ratio | 5 | 2020 | 9716 | 0.060 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2009 | 741 | 0.060 |
Why?
|
| Diagnosis-Related Groups | 2 | 2016 | 450 | 0.060 |
Why?
|
| Triiodothyronine | 1 | 2005 | 493 | 0.060 |
Why?
|
| Leukocyte Count | 2 | 1998 | 1600 | 0.060 |
Why?
|
| Hydroxyurea | 1 | 2005 | 282 | 0.060 |
Why?
|
| Cell Separation | 1 | 2009 | 1720 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2011 | 1652 | 0.060 |
Why?
|
| Molecular Imaging | 1 | 2010 | 818 | 0.050 |
Why?
|
| Neuralgia | 1 | 2010 | 600 | 0.050 |
Why?
|
| Karyotyping | 2 | 2016 | 1171 | 0.050 |
Why?
|
| Graft Occlusion, Vascular | 2 | 1999 | 560 | 0.050 |
Why?
|
| Lactose | 2 | 2000 | 95 | 0.050 |
Why?
|
| Hypothalamus | 6 | 1971 | 998 | 0.050 |
Why?
|
| Reference Values | 3 | 2002 | 4925 | 0.050 |
Why?
|
| Elasticity | 3 | 2016 | 652 | 0.050 |
Why?
|
| Drug Combinations | 1 | 2009 | 2025 | 0.050 |
Why?
|
| Chronic Disease | 4 | 2010 | 9287 | 0.050 |
Why?
|
| Polystyrenes | 2 | 2000 | 104 | 0.050 |
Why?
|
| Cleavage Stage, Ovum | 2 | 1999 | 44 | 0.050 |
Why?
|
| Analgesics | 1 | 2010 | 1065 | 0.050 |
Why?
|
| Blood Pressure Determination | 1 | 2007 | 640 | 0.050 |
Why?
|
| Blood Pressure | 5 | 2009 | 8525 | 0.050 |
Why?
|
| Myocytes, Smooth Muscle | 3 | 2016 | 686 | 0.050 |
Why?
|
| Mitral Valve Stenosis | 3 | 2012 | 348 | 0.050 |
Why?
|
| Cytarabine | 1 | 2005 | 696 | 0.050 |
Why?
|
| Microfluidics | 2 | 2006 | 652 | 0.050 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2009 | 806 | 0.050 |
Why?
|
| RNA, Messenger | 7 | 2015 | 12766 | 0.050 |
Why?
|
| Piperazines | 1 | 2013 | 2525 | 0.050 |
Why?
|
| Elastin | 2 | 2001 | 301 | 0.050 |
Why?
|
| Catheterization, Peripheral | 1 | 2006 | 345 | 0.050 |
Why?
|
| Linear Models | 4 | 2014 | 5877 | 0.050 |
Why?
|
| Liver Diseases | 1 | 2011 | 1302 | 0.050 |
Why?
|
| Child Development | 2 | 1991 | 2285 | 0.050 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2006 | 675 | 0.050 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2008 | 1259 | 0.050 |
Why?
|
| Proteins | 1 | 2017 | 6029 | 0.050 |
Why?
|
| Isometric Contraction | 1 | 2002 | 146 | 0.050 |
Why?
|
| Microscopy | 1 | 2007 | 885 | 0.050 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2006 | 409 | 0.050 |
Why?
|
| Anisotropy | 3 | 2014 | 1278 | 0.050 |
Why?
|
| Femoral Artery | 1 | 2006 | 835 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 6 | 2000 | 1628 | 0.050 |
Why?
|
| Sternum | 3 | 2000 | 175 | 0.050 |
Why?
|
| Device Approval | 2 | 2000 | 165 | 0.050 |
Why?
|
| Immunosuppressive Agents | 2 | 2013 | 4166 | 0.050 |
Why?
|
| DNA | 4 | 2002 | 7233 | 0.050 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2017 | 1108 | 0.050 |
Why?
|
| Neurodegenerative Diseases | 1 | 2011 | 1084 | 0.050 |
Why?
|
| Genes, Immediate-Early | 1 | 2002 | 101 | 0.050 |
Why?
|
| Cerebrovascular Circulation | 2 | 2009 | 2733 | 0.050 |
Why?
|
| Situs Inversus | 2 | 2010 | 63 | 0.050 |
Why?
|
| Disease-Free Survival | 4 | 2014 | 6828 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 10827 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2014 | 4742 | 0.050 |
Why?
|
| Apoptosis | 2 | 2008 | 9501 | 0.050 |
Why?
|
| Coculture Techniques | 2 | 2015 | 1342 | 0.050 |
Why?
|
| Embryo Transfer | 3 | 1999 | 522 | 0.050 |
Why?
|
| Pyrimidines | 1 | 2013 | 3016 | 0.050 |
Why?
|
| Arteriovenous Fistula | 2 | 1995 | 314 | 0.050 |
Why?
|
| Graft vs Host Disease | 2 | 2011 | 3025 | 0.050 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2000 | 28 | 0.050 |
Why?
|
| Anticoagulants | 1 | 1996 | 4897 | 0.050 |
Why?
|
| Europe | 2 | 2015 | 3441 | 0.050 |
Why?
|
| Regression Analysis | 5 | 2008 | 6360 | 0.050 |
Why?
|
| Proteoglycans | 2 | 2001 | 801 | 0.050 |
Why?
|
| Aortic Stenosis, Subvalvular | 1 | 2000 | 10 | 0.050 |
Why?
|
| Microinjections | 2 | 1999 | 321 | 0.050 |
Why?
|
| Lumbosacral Region | 1 | 2002 | 291 | 0.050 |
Why?
|
| Vascular Fistula | 1 | 2000 | 50 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 2 | 2001 | 392 | 0.050 |
Why?
|
| Surface Properties | 2 | 2000 | 1161 | 0.050 |
Why?
|
| Treatment Failure | 5 | 2009 | 2648 | 0.040 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2001 | 137 | 0.040 |
Why?
|
| Ventricular Dysfunction | 2 | 2004 | 145 | 0.040 |
Why?
|
| Carcinoma, Small Cell | 1 | 1982 | 416 | 0.040 |
Why?
|
| Czech Republic | 1 | 2020 | 73 | 0.040 |
Why?
|
| Methods | 8 | 1993 | 1074 | 0.040 |
Why?
|
| Aluminum Oxide | 1 | 2000 | 41 | 0.040 |
Why?
|
| Biotechnology | 2 | 1999 | 281 | 0.040 |
Why?
|
| Cell Proliferation | 4 | 2011 | 10446 | 0.040 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 6538 | 0.040 |
Why?
|
| Canada | 2 | 2019 | 2128 | 0.040 |
Why?
|
| Emergencies | 1 | 1986 | 1211 | 0.040 |
Why?
|
| Coronary Stenosis | 1 | 2006 | 820 | 0.040 |
Why?
|
| Internship and Residency | 1 | 2020 | 5870 | 0.040 |
Why?
|
| Alkanes | 1 | 1999 | 42 | 0.040 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2001 | 246 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 2001 | 1316 | 0.040 |
Why?
|
| Textiles | 1 | 1999 | 45 | 0.040 |
Why?
|
| Ischemic Preconditioning, Myocardial | 1 | 1999 | 69 | 0.040 |
Why?
|
| Implants, Experimental | 1 | 2000 | 99 | 0.040 |
Why?
|
| Drug Stability | 1 | 2000 | 290 | 0.040 |
Why?
|
| Oligospermia | 1 | 1999 | 59 | 0.040 |
Why?
|
| Certification | 2 | 2014 | 421 | 0.040 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1878 | 0.040 |
Why?
|
| Lipid Peroxidation | 1 | 2000 | 271 | 0.040 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2007 | 1489 | 0.040 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2023 | 1006 | 0.040 |
Why?
|
| Appetite | 3 | 1970 | 247 | 0.040 |
Why?
|
| Lymphoma | 1 | 2009 | 1898 | 0.040 |
Why?
|
| Pulmonary Diffusing Capacity | 1 | 1999 | 94 | 0.040 |
Why?
|
| Coronary Angiography | 3 | 2006 | 4563 | 0.040 |
Why?
|
| Tissue Donors | 3 | 2015 | 2313 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2020 | 315 | 0.040 |
Why?
|
| DNA Replication | 1 | 2006 | 1412 | 0.040 |
Why?
|
| Subclavian Artery | 2 | 1999 | 134 | 0.040 |
Why?
|
| Doxorubicin | 1 | 2006 | 2209 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 4013 | 0.040 |
Why?
|
| Venous Pressure | 2 | 1995 | 57 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2009 | 2062 | 0.040 |
Why?
|
| Annual Reports as Topic | 1 | 2018 | 36 | 0.040 |
Why?
|
| Aneurysm | 1 | 2002 | 337 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 15 | 1 | 2020 | 362 | 0.040 |
Why?
|
| Cost Savings | 2 | 2014 | 920 | 0.040 |
Why?
|
| Smoking | 3 | 2012 | 9073 | 0.040 |
Why?
|
| Sperm Injections, Intracytoplasmic | 1 | 1999 | 156 | 0.040 |
Why?
|
| Mitral Valve Prolapse | 2 | 2019 | 215 | 0.040 |
Why?
|
| Blood Glucose | 4 | 1991 | 6381 | 0.040 |
Why?
|
| Moral Obligations | 1 | 2019 | 93 | 0.040 |
Why?
|
| Platelet Transfusion | 1 | 1981 | 294 | 0.040 |
Why?
|
| Cell Survival | 4 | 2014 | 5797 | 0.040 |
Why?
|
| Acute Disease | 3 | 2005 | 7269 | 0.040 |
Why?
|
| Attitude to Computers | 1 | 2019 | 195 | 0.040 |
Why?
|
| Hemoglobins | 2 | 2017 | 1521 | 0.040 |
Why?
|
| Preoperative Period | 2 | 2011 | 555 | 0.040 |
Why?
|
| Vimentin | 2 | 2014 | 255 | 0.040 |
Why?
|
| Hemorrhage | 3 | 2009 | 3600 | 0.040 |
Why?
|
| Pluripotent Stem Cells | 1 | 2005 | 792 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2001 | 406 | 0.040 |
Why?
|
| Longitudinal Studies | 2 | 2012 | 14495 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2013 | 4048 | 0.040 |
Why?
|
| Hodgkin Disease | 1 | 2006 | 1378 | 0.040 |
Why?
|
| Cyclic GMP | 1 | 1999 | 395 | 0.040 |
Why?
|
| Angiocardiography | 3 | 2002 | 153 | 0.040 |
Why?
|
| Spermatozoa | 2 | 1999 | 631 | 0.040 |
Why?
|
| Comparative Effectiveness Research | 2 | 2015 | 718 | 0.040 |
Why?
|
| Heart-Assist Devices | 2 | 1999 | 1291 | 0.040 |
Why?
|
| DiGeorge Syndrome | 1 | 1999 | 185 | 0.040 |
Why?
|
| Embolism | 1 | 1981 | 408 | 0.040 |
Why?
|
| Ovarian Follicle | 1 | 1999 | 244 | 0.040 |
Why?
|
| Psychometrics | 1 | 2007 | 3051 | 0.040 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 4407 | 0.040 |
Why?
|
| Age Distribution | 2 | 2018 | 2893 | 0.040 |
Why?
|
| Capillary Permeability | 1 | 1981 | 768 | 0.040 |
Why?
|
| Task Performance and Analysis | 2 | 2014 | 759 | 0.040 |
Why?
|
| Oocytes | 2 | 1999 | 1165 | 0.040 |
Why?
|
| Heart Rate | 4 | 2008 | 4179 | 0.040 |
Why?
|
| Electrocoagulation | 1 | 1998 | 152 | 0.040 |
Why?
|
| Washington | 1 | 2018 | 312 | 0.040 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2010 | 3986 | 0.040 |
Why?
|
| Embryo Implantation | 1 | 1999 | 270 | 0.040 |
Why?
|
| Lung Transplantation | 2 | 1999 | 1305 | 0.040 |
Why?
|
| Intraoperative Period | 1 | 1998 | 516 | 0.040 |
Why?
|
| Pediatrics | 1 | 2013 | 3586 | 0.040 |
Why?
|
| Heart Conduction System | 3 | 2004 | 1015 | 0.040 |
Why?
|
| Immunohistochemistry | 4 | 2018 | 11071 | 0.040 |
Why?
|
| Tachycardia, Ectopic Junctional | 1 | 1997 | 20 | 0.040 |
Why?
|
| Pneumonia, Bacterial | 1 | 2000 | 319 | 0.040 |
Why?
|
| Antineoplastic Agents | 3 | 2015 | 13630 | 0.040 |
Why?
|
| Culture Media | 2 | 2015 | 900 | 0.040 |
Why?
|
| Myocardial Infarction | 3 | 2014 | 11891 | 0.040 |
Why?
|
| Interferon-alpha | 1 | 2001 | 918 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 2 | 1994 | 1602 | 0.040 |
Why?
|
| Medicare Part B | 1 | 1998 | 117 | 0.040 |
Why?
|
| Potassium | 2 | 1994 | 1313 | 0.040 |
Why?
|
| Intraoperative Complications | 4 | 2011 | 1186 | 0.040 |
Why?
|
| Body Temperature | 2 | 1992 | 777 | 0.040 |
Why?
|
| Esophageal Perforation | 1 | 1977 | 65 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 695 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 1997 | 180 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2013 | 8950 | 0.030 |
Why?
|
| Aquaporins | 1 | 1997 | 174 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 2 | 2002 | 908 | 0.030 |
Why?
|
| Surgical Mesh | 1 | 1999 | 311 | 0.030 |
Why?
|
| Nitroprusside | 2 | 2000 | 273 | 0.030 |
Why?
|
| Veins | 1 | 2000 | 765 | 0.030 |
Why?
|
| Ultrasonic Therapy | 1 | 1998 | 215 | 0.030 |
Why?
|
| Models, Animal | 2 | 2013 | 2117 | 0.030 |
Why?
|
| Double-Blind Method | 4 | 2015 | 12427 | 0.030 |
Why?
|
| Sheep, Domestic | 1 | 2016 | 50 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2001 | 859 | 0.030 |
Why?
|
| Tachycardia, Paroxysmal | 1 | 1996 | 30 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2005 | 2533 | 0.030 |
Why?
|
| Wound Healing | 1 | 2007 | 2788 | 0.030 |
Why?
|
| Retreatment | 1 | 2017 | 600 | 0.030 |
Why?
|
| Ventricular Function, Right | 2 | 2017 | 610 | 0.030 |
Why?
|
| Receptor, Endothelin A | 1 | 1995 | 56 | 0.030 |
Why?
|
| Platelet Count | 1 | 1998 | 777 | 0.030 |
Why?
|
| Confidence Intervals | 4 | 2008 | 2932 | 0.030 |
Why?
|
| Aneuploidy | 1 | 1999 | 551 | 0.030 |
Why?
|
| Orthopedic Procedures | 1 | 2006 | 1263 | 0.030 |
Why?
|
| Regeneration | 1 | 2005 | 1506 | 0.030 |
Why?
|
| Tracheal Neoplasms | 1 | 1976 | 123 | 0.030 |
Why?
|
| Educational Status | 1 | 2023 | 2515 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 2651 | 0.030 |
Why?
|
| Reference Standards | 1 | 2019 | 1004 | 0.030 |
Why?
|
| Infusions, Intravenous | 2 | 2014 | 2234 | 0.030 |
Why?
|
| Body Height | 2 | 2000 | 1570 | 0.030 |
Why?
|
| North America | 1 | 2019 | 1284 | 0.030 |
Why?
|
| Body Weight | 5 | 2000 | 4611 | 0.030 |
Why?
|
| Polyploidy | 1 | 2016 | 119 | 0.030 |
Why?
|
| Bicarbonates | 2 | 1994 | 292 | 0.030 |
Why?
|
| Prenatal Diagnosis | 2 | 2007 | 1264 | 0.030 |
Why?
|
| Tissue Transplantation | 1 | 1996 | 128 | 0.030 |
Why?
|
| Attitude of Health Personnel | 2 | 2019 | 3865 | 0.030 |
Why?
|
| Fees, Medical | 1 | 2015 | 112 | 0.030 |
Why?
|
| Models, Anatomic | 1 | 2019 | 682 | 0.030 |
Why?
|
| Truth Disclosure | 1 | 2019 | 432 | 0.030 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1995 | 221 | 0.030 |
Why?
|
| Tricuspid Valve Stenosis | 1 | 1994 | 27 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 12626 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 1997 | 691 | 0.030 |
Why?
|
| Health Personnel | 1 | 2009 | 3310 | 0.030 |
Why?
|
| Pulsatile Flow | 3 | 2004 | 321 | 0.030 |
Why?
|
| Combined Modality Therapy | 4 | 2013 | 8552 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2001 | 933 | 0.030 |
Why?
|
| Confidentiality | 1 | 2019 | 609 | 0.030 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 1994 | 69 | 0.030 |
Why?
|
| Rats | 4 | 2023 | 23711 | 0.030 |
Why?
|
| Job Description | 1 | 2014 | 59 | 0.030 |
Why?
|
| Infertility, Male | 1 | 1998 | 396 | 0.030 |
Why?
|
| Neurologic Examination | 2 | 1995 | 916 | 0.030 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2018 | 377 | 0.030 |
Why?
|
| Causality | 1 | 2021 | 1242 | 0.030 |
Why?
|
| Heart Aneurysm | 1 | 1995 | 115 | 0.030 |
Why?
|
| Tranexamic Acid | 1 | 1997 | 176 | 0.030 |
Why?
|
| Back Pain | 1 | 2018 | 543 | 0.030 |
Why?
|
| Rats, Inbred Lew | 1 | 2016 | 1154 | 0.030 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 1995 | 149 | 0.030 |
Why?
|
| Electric Impedance | 1 | 1998 | 755 | 0.030 |
Why?
|
| Reperfusion | 1 | 1995 | 271 | 0.030 |
Why?
|
| Calcium Chloride | 1 | 1994 | 78 | 0.030 |
Why?
|
| Hypothermia | 1 | 1995 | 188 | 0.030 |
Why?
|
| Central Nervous System Diseases | 2 | 2009 | 521 | 0.030 |
Why?
|
| Sodium Chloride | 2 | 1994 | 591 | 0.030 |
Why?
|
| Leishmania major | 1 | 1994 | 59 | 0.030 |
Why?
|
| Pulmonary Subvalvular Stenosis | 1 | 1993 | 7 | 0.030 |
Why?
|
| Antifibrinolytic Agents | 1 | 1997 | 292 | 0.030 |
Why?
|
| Potassium Chloride | 1 | 1994 | 230 | 0.030 |
Why?
|
| Rectus Abdominis | 1 | 1994 | 102 | 0.030 |
Why?
|
| Gastrointestinal Diseases | 1 | 2002 | 1190 | 0.030 |
Why?
|
| Theophylline | 1 | 1993 | 131 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 1999 | 1674 | 0.030 |
Why?
|
| Blood Transfusion | 2 | 2017 | 1328 | 0.030 |
Why?
|
| Tissue Culture Techniques | 2 | 2005 | 290 | 0.030 |
Why?
|
| Receptors, Purinergic P1 | 1 | 1993 | 108 | 0.030 |
Why?
|
| Actuarial Analysis | 4 | 1999 | 374 | 0.030 |
Why?
|
| Peptides, Cyclic | 1 | 1995 | 392 | 0.030 |
Why?
|
| Comorbidity | 1 | 2008 | 10551 | 0.030 |
Why?
|
| Goldfish | 2 | 1964 | 65 | 0.030 |
Why?
|
| California | 3 | 2011 | 1416 | 0.030 |
Why?
|
| Hepatitis C, Chronic | 1 | 2001 | 1031 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 1995 | 780 | 0.030 |
Why?
|
| Diastole | 1 | 1995 | 788 | 0.030 |
Why?
|
| Elastic Modulus | 1 | 2014 | 210 | 0.030 |
Why?
|
| Validation Studies as Topic | 1 | 2013 | 162 | 0.030 |
Why?
|
| Feeding Behavior | 3 | 1971 | 3185 | 0.030 |
Why?
|
| Sample Size | 1 | 2016 | 840 | 0.030 |
Why?
|
| Gold | 3 | 1971 | 484 | 0.030 |
Why?
|
| Cell Adhesion | 3 | 2009 | 3094 | 0.030 |
Why?
|
| Stroke Volume | 2 | 2003 | 5523 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 1997 | 656 | 0.030 |
Why?
|
| Information Systems | 1 | 1995 | 398 | 0.030 |
Why?
|
| Long QT Syndrome | 1 | 1997 | 466 | 0.030 |
Why?
|
| Phospholipid Ethers | 1 | 1992 | 9 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2018 | 1630 | 0.030 |
Why?
|
| Goats | 2 | 1969 | 167 | 0.030 |
Why?
|
| Erythropoietin | 1 | 2017 | 720 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2010 | 20509 | 0.030 |
Why?
|
| Biological Assay | 1 | 1995 | 630 | 0.030 |
Why?
|
| Ion Channels | 1 | 1997 | 1043 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2008 | 7475 | 0.030 |
Why?
|
| Anesthesia, Inhalation | 1 | 2013 | 220 | 0.030 |
Why?
|
| Cyclophosphamide | 2 | 2010 | 2221 | 0.030 |
Why?
|
| Interleukin-8 | 1 | 1995 | 698 | 0.030 |
Why?
|
| Blotting, Western | 3 | 2011 | 5039 | 0.030 |
Why?
|
| Climate | 1 | 2013 | 147 | 0.030 |
Why?
|
| Bacterial Infections | 2 | 1998 | 1403 | 0.030 |
Why?
|
| Aortography | 2 | 1993 | 420 | 0.030 |
Why?
|
| Aneurysm, False | 1 | 1995 | 257 | 0.030 |
Why?
|
| Biomimetic Materials | 1 | 2014 | 173 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1996 | 1456 | 0.030 |
Why?
|
| Leishmaniasis, Cutaneous | 1 | 1994 | 136 | 0.030 |
Why?
|
| Platelet Activating Factor | 1 | 1992 | 143 | 0.030 |
Why?
|
| Sick Sinus Syndrome | 1 | 2012 | 45 | 0.020 |
Why?
|
| Needs Assessment | 1 | 2018 | 1139 | 0.020 |
Why?
|
| Pleural Effusion | 2 | 2002 | 342 | 0.020 |
Why?
|
| Cyclopropanes | 1 | 2013 | 431 | 0.020 |
Why?
|
| Prednisone | 2 | 2006 | 1565 | 0.020 |
Why?
|
| Echocardiography, Three-Dimensional | 1 | 2017 | 613 | 0.020 |
Why?
|
| Coccidioidomycosis | 1 | 1991 | 37 | 0.020 |
Why?
|
| Lipopolysaccharides | 2 | 1996 | 2209 | 0.020 |
Why?
|
| Norepinephrine | 2 | 1991 | 900 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2012 | 284 | 0.020 |
Why?
|
| Cardiac Valve Annuloplasty | 1 | 2011 | 51 | 0.020 |
Why?
|
| Sister Chromatid Exchange | 1 | 1991 | 60 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2009 | 12914 | 0.020 |
Why?
|
| Triage | 1 | 2018 | 987 | 0.020 |
Why?
|
| Hepatitis C | 1 | 2001 | 1579 | 0.020 |
Why?
|
| Pregnancy | 8 | 2007 | 29749 | 0.020 |
Why?
|
| Fluconazole | 1 | 1991 | 155 | 0.020 |
Why?
|
| Diabetic Ketoacidosis | 1 | 1994 | 257 | 0.020 |
Why?
|
| Cross Infection | 1 | 2000 | 1434 | 0.020 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 1991 | 38 | 0.020 |
Why?
|
| Dextrocardia | 1 | 2010 | 37 | 0.020 |
Why?
|
| Binding Sites | 1 | 2000 | 6048 | 0.020 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 1008 | 0.020 |
Why?
|
| Clone Cells | 1 | 2014 | 1660 | 0.020 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2014 | 495 | 0.020 |
Why?
|
| Isotonic Solutions | 1 | 1991 | 116 | 0.020 |
Why?
|
| Liver Circulation | 1 | 2011 | 159 | 0.020 |
Why?
|
| Health Services Research | 1 | 1998 | 1810 | 0.020 |
Why?
|
| Phylogeny | 1 | 2018 | 2775 | 0.020 |
Why?
|
| Phytophthora | 1 | 1990 | 5 | 0.020 |
Why?
|
| Hydroxyproline | 2 | 2001 | 110 | 0.020 |
Why?
|
| Administration, Cutaneous | 1 | 2013 | 713 | 0.020 |
Why?
|
| Chytridiomycota | 1 | 1990 | 8 | 0.020 |
Why?
|
| Hospitalization | 2 | 2015 | 10790 | 0.020 |
Why?
|
| X-Ray Microtomography | 1 | 2013 | 443 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 1996 | 4357 | 0.020 |
Why?
|
| Ventricular Septum | 1 | 2011 | 76 | 0.020 |
Why?
|
| Magnesium | 1 | 1994 | 810 | 0.020 |
Why?
|
| Hospital Information Systems | 1 | 2013 | 394 | 0.020 |
Why?
|
| Urban Health | 1 | 1993 | 533 | 0.020 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 730 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2017 | 1046 | 0.020 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 1998 | 1004 | 0.020 |
Why?
|
| Pregnancy Outcome | 2 | 1998 | 2907 | 0.020 |
Why?
|
| Chlamydia Infections | 1 | 1994 | 362 | 0.020 |
Why?
|
| Health Status | 3 | 2013 | 4081 | 0.020 |
Why?
|
| Observation | 1 | 2012 | 312 | 0.020 |
Why?
|
| Models, Economic | 1 | 2014 | 719 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2018 | 1399 | 0.020 |
Why?
|
| Leukopenia | 1 | 2010 | 211 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1990 | 216 | 0.020 |
Why?
|
| Behavior | 2 | 2004 | 540 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2011 | 4573 | 0.020 |
Why?
|
| Catheter Ablation | 2 | 2010 | 2758 | 0.020 |
Why?
|
| Retirement | 1 | 2011 | 199 | 0.020 |
Why?
|
| Sutures | 2 | 2006 | 293 | 0.020 |
Why?
|
| Germany | 1 | 2012 | 873 | 0.020 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 1996 | 819 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2015 | 1436 | 0.020 |
Why?
|
| Computer Simulation | 2 | 2013 | 6218 | 0.020 |
Why?
|
| Czechoslovakia | 1 | 2009 | 6 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 2011 | 8547 | 0.020 |
Why?
|
| Uric Acid | 1 | 2015 | 806 | 0.020 |
Why?
|
| Perioperative Care | 1 | 2017 | 1037 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2001 | 3061 | 0.020 |
Why?
|
| Candidiasis | 1 | 1991 | 363 | 0.020 |
Why?
|
| Neuropsychological Tests | 3 | 2008 | 7021 | 0.020 |
Why?
|
| Glutathione Transferase | 1 | 1991 | 565 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1974 | 0.020 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2013 | 664 | 0.020 |
Why?
|
| Shear Strength | 1 | 2009 | 161 | 0.020 |
Why?
|
| Dissection | 1 | 2010 | 298 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2020 | 2725 | 0.020 |
Why?
|
| Radiology, Interventional | 1 | 2013 | 475 | 0.020 |
Why?
|
| Workload | 1 | 2014 | 847 | 0.020 |
Why?
|
| Plants | 1 | 1990 | 317 | 0.020 |
Why?
|
| Intraoperative Care | 4 | 1997 | 768 | 0.020 |
Why?
|
| Staphylococcal Infections | 2 | 2013 | 1407 | 0.020 |
Why?
|
| Endothelium | 1 | 1991 | 764 | 0.020 |
Why?
|
| Minnesota | 2 | 1999 | 340 | 0.020 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 1992 | 385 | 0.020 |
Why?
|
| Autopsy | 1 | 2012 | 1007 | 0.020 |
Why?
|
| Appetitive Behavior | 1 | 1968 | 39 | 0.020 |
Why?
|
| Anesthetics, Inhalation | 1 | 2013 | 574 | 0.020 |
Why?
|
| Heart Arrest | 1 | 1998 | 1506 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 1991 | 593 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2011 | 865 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2015 | 1724 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2015 | 14372 | 0.020 |
Why?
|
| Sperm Count | 2 | 1999 | 228 | 0.020 |
Why?
|
| Narcotics | 1 | 2010 | 336 | 0.020 |
Why?
|
| Pressure | 1 | 1991 | 1156 | 0.020 |
Why?
|
| Life Expectancy | 1 | 2015 | 1248 | 0.020 |
Why?
|
| HLA Antigens | 1 | 2013 | 1368 | 0.020 |
Why?
|
| Organ Size | 1 | 2013 | 2254 | 0.020 |
Why?
|
| Plant Proteins | 1 | 1990 | 370 | 0.020 |
Why?
|
| Brain | 3 | 2003 | 26951 | 0.020 |
Why?
|
| Granulation Tissue | 1 | 2007 | 92 | 0.020 |
Why?
|
| Venae Cavae | 1 | 1987 | 41 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 693 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 2011 | 539 | 0.020 |
Why?
|
| Polypharmacy | 1 | 2010 | 307 | 0.020 |
Why?
|
| Seasons | 1 | 2013 | 1522 | 0.020 |
Why?
|
| Propensity Score | 1 | 2015 | 1928 | 0.020 |
Why?
|
| Tauopathies | 1 | 2011 | 317 | 0.020 |
Why?
|
| Decision Support Techniques | 1 | 2017 | 2001 | 0.020 |
Why?
|
| Infant Mortality | 1 | 2012 | 757 | 0.020 |
Why?
|
| Tachycardia, Ventricular | 1 | 1996 | 1303 | 0.020 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2010 | 378 | 0.020 |
Why?
|
| Polyethylene Glycols | 2 | 2007 | 1189 | 0.020 |
Why?
|
| Microscopy, Confocal | 2 | 2005 | 1972 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 1991 | 704 | 0.020 |
Why?
|
| Foreign-Body Reaction | 1 | 2007 | 157 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2023 | 17790 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2012 | 8555 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2000 | 3976 | 0.020 |
Why?
|
| Monitoring, Physiologic | 3 | 1993 | 1784 | 0.020 |
Why?
|
| Cell Shape | 1 | 2007 | 372 | 0.020 |
Why?
|
| Sports | 1 | 2012 | 700 | 0.020 |
Why?
|
| Anesthesia | 2 | 2008 | 1584 | 0.020 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 3242 | 0.020 |
Why?
|
| Developing Countries | 1 | 2018 | 2868 | 0.020 |
Why?
|
| Diet, Reducing | 2 | 1966 | 488 | 0.020 |
Why?
|
| Fetal Heart | 1 | 2007 | 281 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2016 | 10344 | 0.020 |
Why?
|
| Neutropenia | 1 | 2010 | 884 | 0.020 |
Why?
|
| Prostaglandins E | 1 | 1985 | 169 | 0.020 |
Why?
|
| Tunica Intima | 1 | 2007 | 459 | 0.020 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 1968 | 351 | 0.020 |
Why?
|
| Pulmonary Embolism | 1 | 1998 | 2543 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 1971 | 1112 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2013 | 1462 | 0.020 |
Why?
|
| Cost of Illness | 1 | 2015 | 1940 | 0.020 |
Why?
|
| Bleomycin | 1 | 2006 | 495 | 0.020 |
Why?
|
| Mice | 8 | 2011 | 81208 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2007 | 998 | 0.020 |
Why?
|
| Physiology, Comparative | 1 | 1964 | 8 | 0.020 |
Why?
|
| Atrial Fibrillation | 1 | 2003 | 5209 | 0.010 |
Why?
|
| Family | 1 | 2015 | 3189 | 0.010 |
Why?
|
| Kinetics | 3 | 2001 | 6377 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 1996 | 7593 | 0.010 |
Why?
|
| Bone Nails | 1 | 2006 | 218 | 0.010 |
Why?
|
| Vinblastine | 1 | 2006 | 487 | 0.010 |
Why?
|
| Spleen | 3 | 1995 | 2298 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 2 | 2000 | 7408 | 0.010 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2011 | 833 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2013 | 1958 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2011 | 2698 | 0.010 |
Why?
|
| Nutritional Physiological Phenomena | 3 | 1969 | 363 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2016 | 3562 | 0.010 |
Why?
|
| Rabbits | 1 | 1990 | 4773 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 2418 | 0.010 |
Why?
|
| Hyperglycemia | 2 | 1970 | 1380 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2010 | 3607 | 0.010 |
Why?
|
| Suture Techniques | 2 | 2006 | 790 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 13451 | 0.010 |
Why?
|
| Muscle, Skeletal | 2 | 1995 | 4925 | 0.010 |
Why?
|
| Food | 3 | 1966 | 771 | 0.010 |
Why?
|
| Cineangiography | 2 | 1993 | 113 | 0.010 |
Why?
|
| Alleles | 1 | 2014 | 6898 | 0.010 |
Why?
|
| Vincristine | 1 | 2006 | 1039 | 0.010 |
Why?
|
| Schools | 1 | 2012 | 1480 | 0.010 |
Why?
|
| Cell Movement | 1 | 2015 | 5206 | 0.010 |
Why?
|
| Dacarbazine | 1 | 2006 | 560 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 2003 | 79 | 0.010 |
Why?
|
| Glucagon | 3 | 1971 | 532 | 0.010 |
Why?
|
| Algorithms | 2 | 2016 | 13981 | 0.010 |
Why?
|
| Radiosurgery | 1 | 1992 | 1343 | 0.010 |
Why?
|
| Molecular Sequence Data | 2 | 2011 | 17624 | 0.010 |
Why?
|
| Phosphorylation | 2 | 2011 | 8313 | 0.010 |
Why?
|
| Prosthesis-Related Infections | 1 | 2008 | 487 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2004 | 441 | 0.010 |
Why?
|
| Brain Ischemia | 2 | 1993 | 3127 | 0.010 |
Why?
|
| Blood Cells | 1 | 2004 | 305 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 4899 | 0.010 |
Why?
|
| Pronase | 2 | 1990 | 30 | 0.010 |
Why?
|
| Transfection | 1 | 2010 | 5781 | 0.010 |
Why?
|
| Reperfusion Injury | 2 | 2003 | 1023 | 0.010 |
Why?
|
| Geriatric Assessment | 1 | 2010 | 1405 | 0.010 |
Why?
|
| Genes, jun | 1 | 2002 | 68 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2014 | 3616 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2011 | 4122 | 0.010 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2002 | 102 | 0.010 |
Why?
|
| Serum Globulins | 1 | 1981 | 24 | 0.010 |
Why?
|
| Rheology | 1 | 2003 | 348 | 0.010 |
Why?
|
| Patients | 1 | 2008 | 906 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2007 | 2295 | 0.010 |
Why?
|
| DNA Repair | 1 | 1991 | 2039 | 0.010 |
Why?
|
| Genes, fos | 1 | 2002 | 174 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1969 | 1804 | 0.010 |
Why?
|
| Collagenases | 1 | 2002 | 221 | 0.010 |
Why?
|
| Cadaver | 1 | 2006 | 1345 | 0.010 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2010 | 3529 | 0.010 |
Why?
|
| Lymph | 1 | 1981 | 77 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2008 | 1392 | 0.010 |
Why?
|
| Rotation | 1 | 2003 | 514 | 0.010 |
Why?
|
| Immunologic Factors | 1 | 2010 | 1588 | 0.010 |
Why?
|
| Biopsy | 2 | 1990 | 6771 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2001 | 97 | 0.010 |
Why?
|
| Hematoma | 2 | 1998 | 769 | 0.010 |
Why?
|
| Fishes | 1 | 1964 | 601 | 0.010 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2001 | 142 | 0.010 |
Why?
|
| Central Venous Pressure | 1 | 2000 | 79 | 0.010 |
Why?
|
| Regional Medical Programs | 1 | 2001 | 68 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 1995 | 3527 | 0.010 |
Why?
|
| Stents | 1 | 2013 | 3314 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 11152 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2002 | 514 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2011 | 22053 | 0.010 |
Why?
|
| Research Design | 1 | 2016 | 6180 | 0.010 |
Why?
|
| Connective Tissue Cells | 1 | 2000 | 50 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1986 | 2362 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 2001 | 204 | 0.010 |
Why?
|
| Health Behavior | 1 | 1991 | 2622 | 0.010 |
Why?
|
| Cells, Immobilized | 1 | 1999 | 35 | 0.010 |
Why?
|
| Lactates | 2 | 1971 | 404 | 0.010 |
Why?
|
| Technology Transfer | 1 | 1999 | 42 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 8158 | 0.010 |
Why?
|
| Partial Pressure | 1 | 1999 | 245 | 0.010 |
Why?
|
| Diploidy | 1 | 1999 | 132 | 0.010 |
Why?
|
| Microcirculation | 1 | 2004 | 1278 | 0.010 |
Why?
|
| Gelatin | 1 | 2001 | 221 | 0.010 |
Why?
|
| Rumen | 2 | 1969 | 18 | 0.010 |
Why?
|
| Intelligence Tests | 1 | 2000 | 500 | 0.010 |
Why?
|
| Massachusetts | 1 | 2012 | 8803 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 1999 | 239 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 1968 | 1902 | 0.010 |
Why?
|
| Angioplasty | 1 | 2002 | 361 | 0.010 |
Why?
|
| Disease Management | 1 | 2010 | 2514 | 0.010 |
Why?
|
| Prevalence | 4 | 2003 | 15687 | 0.010 |
Why?
|
| Immediate-Early Proteins | 1 | 2002 | 449 | 0.010 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2001 | 461 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1996 | 3804 | 0.010 |
Why?
|
| Cell Line | 1 | 1993 | 15620 | 0.010 |
Why?
|
| Albumins | 1 | 1981 | 575 | 0.010 |
Why?
|
| Enteral Nutrition | 1 | 2004 | 785 | 0.010 |
Why?
|
| Decision Trees | 1 | 2000 | 506 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 1744 | 0.010 |
Why?
|
| Streptokinase | 1 | 1998 | 187 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 1999 | 231 | 0.010 |
Why?
|
| Williams Syndrome | 1 | 2000 | 193 | 0.010 |
Why?
|
| Zona Pellucida | 1 | 1998 | 14 | 0.010 |
Why?
|
| Serum Albumin | 1 | 1981 | 674 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 9530 | 0.010 |
Why?
|
| Sperm Motility | 1 | 1999 | 265 | 0.010 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 1987 | 1311 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1982 | 13262 | 0.010 |
Why?
|
| Aquaporin 1 | 1 | 1997 | 57 | 0.010 |
Why?
|
| Cutaneous Fistula | 1 | 1998 | 79 | 0.010 |
Why?
|
| Osseointegration | 1 | 1999 | 274 | 0.010 |
Why?
|
| Hemostasis, Surgical | 1 | 1998 | 129 | 0.010 |
Why?
|
| Motor Activity | 1 | 1968 | 2687 | 0.010 |
Why?
|
| Ventilator Weaning | 1 | 1999 | 161 | 0.010 |
Why?
|
| Staphylococcal Skin Infections | 1 | 1998 | 78 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2004 | 1343 | 0.010 |
Why?
|
| Equipment and Supplies | 1 | 2000 | 275 | 0.010 |
Why?
|
| Skin | 2 | 2005 | 4466 | 0.010 |
Why?
|
| Procainamide | 1 | 1997 | 56 | 0.010 |
Why?
|
| Acetates | 2 | 1969 | 321 | 0.010 |
Why?
|
| Silicones | 1 | 1998 | 227 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2002 | 1055 | 0.010 |
Why?
|
| Protein Engineering | 1 | 2001 | 541 | 0.010 |
Why?
|
| Coated Materials, Biocompatible | 1 | 1999 | 318 | 0.010 |
Why?
|
| Electromagnetic Phenomena | 1 | 1998 | 161 | 0.010 |
Why?
|
| General Surgery | 1 | 2008 | 1678 | 0.010 |
Why?
|
| Tomography, X-Ray | 1 | 1976 | 60 | 0.010 |
Why?
|
| Fertilization | 1 | 1998 | 197 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1996 | 100 | 0.010 |
Why?
|
| Hunger | 2 | 1970 | 206 | 0.010 |
Why?
|
| Dogs | 2 | 1973 | 3841 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2004 | 2208 | 0.010 |
Why?
|
| Thionucleotides | 1 | 1996 | 112 | 0.010 |
Why?
|
| Medical Informatics | 1 | 2003 | 732 | 0.010 |
Why?
|
| Rupture, Spontaneous | 1 | 1977 | 356 | 0.010 |
Why?
|
| Maternal Age | 1 | 1999 | 807 | 0.010 |
Why?
|
| Blastocyst | 1 | 1999 | 433 | 0.010 |
Why?
|
| Temperature | 1 | 2003 | 2221 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1977 | 303 | 0.010 |
Why?
|
| Methylmethacrylates | 1 | 1996 | 67 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 1964 | 1866 | 0.010 |
Why?
|
| Hypertension | 2 | 1993 | 8594 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1999 | 1490 | 0.010 |
Why?
|
| Feedback | 2 | 1970 | 791 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2000 | 978 | 0.010 |
Why?
|
| Income | 1 | 2004 | 1875 | 0.010 |
Why?
|
| Benzophenones | 1 | 1996 | 58 | 0.010 |
Why?
|
| Syndrome | 1 | 2002 | 3280 | 0.010 |
Why?
|
| Polyvinyl Alcohol | 1 | 1996 | 73 | 0.010 |
Why?
|
| Research | 1 | 1964 | 1974 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2004 | 1881 | 0.010 |
Why?
|
| Respiratory Function Tests | 1 | 2000 | 1683 | 0.010 |
Why?
|
| Membrane Proteins | 3 | 2002 | 7850 | 0.010 |
Why?
|
| Intestines | 1 | 1964 | 1907 | 0.010 |
Why?
|
| Cytokines | 2 | 2004 | 7343 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2004 | 2092 | 0.010 |
Why?
|
| Medicaid | 1 | 2008 | 2815 | 0.010 |
Why?
|
| Ketones | 1 | 1996 | 183 | 0.010 |
Why?
|
| Factor VIII | 1 | 1997 | 349 | 0.010 |
Why?
|
| Hepacivirus | 1 | 2001 | 1334 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1998 | 1975 | 0.010 |
Why?
|
| Body Surface Area | 1 | 1994 | 197 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1997 | 1991 | 0.010 |
Why?
|
| Bone Cements | 1 | 1996 | 324 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2004 | 3528 | 0.010 |
Why?
|
| Cell Membrane | 2 | 1996 | 3682 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2004 | 2688 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1997 | 1705 | 0.010 |
Why?
|
| Cell Hypoxia | 1 | 1996 | 658 | 0.010 |
Why?
|
| Analgesics, Opioid | 1 | 2010 | 3763 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 1998 | 1832 | 0.010 |
Why?
|
| Hemorrhagic Disorders | 1 | 1973 | 35 | 0.010 |
Why?
|
| Cognition | 1 | 1991 | 6957 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 1998 | 833 | 0.010 |
Why?
|
| Safety | 1 | 1998 | 1148 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1996 | 2186 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1999 | 2506 | 0.010 |
Why?
|
| Educational Measurement | 1 | 2000 | 1248 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2001 | 2838 | 0.010 |
Why?
|
| Abortion, Spontaneous | 1 | 1998 | 530 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2000 | 1827 | 0.010 |
Why?
|
| Biological Products | 1 | 2002 | 916 | 0.010 |
Why?
|
| Bone Density | 1 | 2006 | 3534 | 0.010 |
Why?
|
| Adipose Tissue | 3 | 1971 | 3301 | 0.010 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 1997 | 784 | 0.010 |
Why?
|
| Peptides | 1 | 2004 | 4354 | 0.010 |
Why?
|
| Blood Volume | 1 | 1993 | 550 | 0.010 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1993 | 273 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 4169 | 0.010 |
Why?
|
| Nutritional Sciences | 1 | 1953 | 143 | 0.010 |
Why?
|
| ROC Curve | 1 | 1999 | 3568 | 0.010 |
Why?
|
| Patient Satisfaction | 1 | 2004 | 3448 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1900 | 0.010 |
Why?
|
| Stroke | 1 | 2014 | 9962 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1995 | 2262 | 0.010 |
Why?
|
| Amphotericin B | 1 | 1991 | 142 | 0.010 |
Why?
|
| Airway Obstruction | 1 | 1976 | 662 | 0.010 |
Why?
|
| Drainage | 1 | 1977 | 1161 | 0.010 |
Why?
|
| Clinical Trials as Topic | 2 | 1993 | 8056 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2014 | 23376 | 0.010 |
Why?
|
| Bacteremia | 1 | 1998 | 980 | 0.010 |
Why?
|
| Tissue Extracts | 1 | 1971 | 140 | 0.010 |
Why?
|
| Radio Waves | 1 | 1992 | 250 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 1997 | 1440 | 0.010 |
Why?
|
| Water | 1 | 1997 | 1407 | 0.010 |
Why?
|
| Hospitals, University | 1 | 1993 | 568 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 1997 | 1157 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1971 | 412 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1994 | 554 | 0.010 |
Why?
|
| Cross-Sectional Studies | 3 | 1997 | 25942 | 0.010 |
Why?
|
| Hospitals, Veterans | 1 | 1993 | 398 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1981 | 2520 | 0.010 |
Why?
|
| Formates | 1 | 1969 | 40 | 0.010 |
Why?
|
| Electroencephalography | 2 | 1997 | 6189 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1990 | 283 | 0.010 |
Why?
|
| Mutation | 1 | 2014 | 29932 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 1993 | 1578 | 0.010 |
Why?
|
| Angioplasty, Balloon | 1 | 1993 | 597 | 0.010 |
Why?
|
| Appetite Regulation | 1 | 1970 | 84 | 0.010 |
Why?
|
| Sulfur | 1 | 1970 | 163 | 0.010 |
Why?
|
| Emergency Medical Services | 1 | 2001 | 1925 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 1998 | 2108 | 0.010 |
Why?
|
| Diagnostic Errors | 1 | 1976 | 1266 | 0.010 |
Why?
|
| Haplorhini | 1 | 1970 | 529 | 0.010 |
Why?
|
| Propionates | 1 | 1969 | 182 | 0.010 |
Why?
|
| Butyrates | 1 | 1969 | 169 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1971 | 1385 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1969 | 459 | 0.010 |
Why?
|
| Gene Expression | 1 | 2002 | 7588 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1991 | 639 | 0.000 |
Why?
|
| Horns | 1 | 1968 | 9 | 0.000 |
Why?
|
| Fibrinolytic Agents | 1 | 1998 | 2167 | 0.000 |
Why?
|
| Cross-Cultural Comparison | 1 | 1991 | 633 | 0.000 |
Why?
|
| Hypertrophy | 1 | 1990 | 555 | 0.000 |
Why?
|
| Psychology | 1 | 1970 | 355 | 0.000 |
Why?
|
| Epinephrine | 1 | 1971 | 791 | 0.000 |
Why?
|
| Pentobarbital | 1 | 1968 | 153 | 0.000 |
Why?
|
| Defibrillators, Implantable | 1 | 1997 | 1499 | 0.000 |
Why?
|
| Diet Surveys | 1 | 1991 | 1161 | 0.000 |
Why?
|
| Lactation | 1 | 1970 | 397 | 0.000 |
Why?
|
| Chemoreceptor Cells | 1 | 1967 | 89 | 0.000 |
Why?
|
| Ischemia | 1 | 1996 | 1893 | 0.000 |
Why?
|
| False Negative Reactions | 1 | 1988 | 573 | 0.000 |
Why?
|
| History, Ancient | 1 | 1967 | 211 | 0.000 |
Why?
|
| Injections | 1 | 1969 | 830 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1998 | 1913 | 0.000 |
Why?
|
| Phosphates | 1 | 1990 | 772 | 0.000 |
Why?
|
| Down Syndrome | 1 | 1994 | 892 | 0.000 |
Why?
|
| Dentistry | 1 | 1967 | 117 | 0.000 |
Why?
|
| Phosphotransferases | 1 | 1967 | 303 | 0.000 |
Why?
|
| Tissue and Organ Procurement | 1 | 1994 | 944 | 0.000 |
Why?
|
| Hypothalamic Diseases | 1 | 1967 | 134 | 0.000 |
Why?
|
| False Positive Reactions | 1 | 1988 | 956 | 0.000 |
Why?
|
| Gastrointestinal Motility | 1 | 1967 | 234 | 0.000 |
Why?
|
| Alprostadil | 1 | 1985 | 86 | 0.000 |
Why?
|
| Arteries | 1 | 1990 | 1126 | 0.000 |
Why?
|
| Seizures | 1 | 1997 | 2917 | 0.000 |
Why?
|
| History, 19th Century | 1 | 1967 | 720 | 0.000 |
Why?
|
| Autonomic Nervous System | 1 | 1969 | 697 | 0.000 |
Why?
|
| Sodium | 1 | 1969 | 1594 | 0.000 |
Why?
|
| Hot Temperature | 1 | 1990 | 1435 | 0.000 |
Why?
|
| Antihypertensive Agents | 1 | 1993 | 2061 | 0.000 |
Why?
|
| Neoplasms | 1 | 1991 | 22072 | 0.000 |
Why?
|
| Fasting | 1 | 1968 | 1603 | 0.000 |
Why?
|
| Diagnosis, Differential | 1 | 1976 | 12965 | 0.000 |
Why?
|
| Cell Nucleus | 1 | 1990 | 2907 | 0.000 |
Why?
|
| Phosphoproteins | 1 | 1990 | 2440 | 0.000 |
Why?
|
| Islets of Langerhans | 1 | 1967 | 1345 | 0.000 |
Why?
|
| Social Class | 1 | 1967 | 2005 | 0.000 |
Why?
|
| Epilepsy | 1 | 1993 | 3267 | 0.000 |
Why?
|
| Insulin | 1 | 1971 | 6597 | 0.000 |
Why?
|
| Insulin Resistance | 1 | 1970 | 3959 | 0.000 |
Why?
|
| Pregnancy Complications | 1 | 1970 | 2942 | 0.000 |
Why?
|
| Mass Screening | 1 | 1991 | 5423 | 0.000 |
Why?
|
| Diet | 1 | 1968 | 8010 | 0.000 |
Why?
|